Works by Mita, Monica

Results: 57

Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors.

Published in:

2016

By:

Mita, Monica;
Nemunaitis, John;
Grilley-Olson, Juneko;
El-Rayes, Bassil;
Bekaii-Saab, Tanios;
Harvey, R.;
Marshall, John;
Zhang, Xiaoping;
Strout, Vincent;
Mita, Monica M;
Harvey, R Donald

Publication type:

journal article

Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.

Published in:

2016

By:

Sarantopoulos, John;
Mita, Monica;
Birrer, Michael;
Cranmer, Lee;
Campos, Luis;
Zhang, Xiaoping;
Bristow, Penelope;
Kaito, Hidekuni;
Strout, Vincent;
Camacho, Luis;
Mita, Monica M;
Birrer, Michael J;
Cranmer, Lee D;
Campos, Luis T;
Camacho, Luis H

Publication type:

journal article

Clinical activity of mammalian target of rapamycin inhibitors in solid tumors.

Published in:

2011

By:

Alvarado, Yesid;
Mita, Monica;
Vemulapalli, Sushma;
Mahalingam, Devalingam;
Mita, Alain;
Mita, Monica M;
Mita, Alain C

Publication type:

journal article

Bromodomain inhibitors a decade later: a promise unfulfilled?

Published in:

2020

By:

Mita, Monica M.;
Mita, Alain C.

Publication type:

Editorial

Bromodomain inhibitors a decade later: a promise unfulfilled?

Published in:

2020

By:

Mita, Monica M.;
Mita, Alain C.

Publication type:

Editorial

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.

Published in:

2020

By:

Voss, Martin H.;
Gordon, Michael S.;
Mita, Monica;
Rini, Brian;
Makker, Vicky;
Macarulla, Teresa;
Smith, David C.;
Cervantes, Andrés;
Puzanov, Igor;
Pili, Roberto;
Wang, Ding;
Jalal, Shadia;
Pant, Shubham;
Patel, Manish R.;
Neuwirth, Rachel l.;
Enke, Aaron;
Shou, Yaping;
Sedarati, Farhad;
Faller, Douglas V.;
Burris III, Howard A.

Publication type:

journal article

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas.

Published in:

2019

By:

Lin, Chia-Chi;
Arkenau, Hendrik-Tobias;
Lu, Sharon;
Sachdev, Jasgit;
de Castro Carpeño, Javier;
Mita, Monica;
Dziadziuszko, Rafal;
Su, Wu-Chou;
Bobilev, Dmitri;
Hughes, Lorraine;
Chan, Jian;
Zhang, Zhi-Yi;
Weiss, Glen J.

Publication type:

journal article

A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours.

Published in:

2018

By:

Schram, Alison M.;
Gandhi, Leena;
Mita, Monica M.;
Damstrup, Lars;
Campana, Frank;
Hidalgo, Manuel;
Grande, Enrique;
Hyman, David M.;
Heist, Rebecca S.

Publication type:

journal article

Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.

Published in:

2017

By:

Mita, Monica M;
Mita, Alain C;
Moseley, Jennifer L;
Poon, Jennifer;
Small, Karen A;
Jou, Ying-Ming;
Kirschmeier, Paul;
Zhang, Da;
Zhu, Yali;
Statkevich, Paul;
Sankhala, Kamelesh K;
Sarantopoulos, John;
Cleary, James M;
Chirieac, Lucian R;
Rodig, Scott J;
Bannerji, Rajat;
Shapiro, Geoffrey I

Publication type:

journal article

Incidence of Mucositis in Patients Treated With Temsirolimus-Based Regimens and Correlation to Treatment Response.

Published in:

Oncologist, 2014, v. 19, n. 4, p. 426, doi. 10.1634/theoncologist.2013-0231

By:

Liu, Xiaochun;
LoRusso, Patricia;
Mita, Monica;
Piha‐Paul, Sarina;
Hong, David S.;
Fu, Siqing;
McQuinn, Lacey;
Asatiani, Ekaterine;
Doyle, Lawrence A.;
Chen, Helen X.;
Hess, Kenneth R.;
Kurzrock, Razelle;
Naing, Aung

Publication type:

Article

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.

Published in:

PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221994

By:

Wolin, Edward;
Mita, Alain;
Mahipal, Amit;
Meyer, Tim;
Bendell, Johanna;
Nemunaitis, John;
Munster, Pam N.;
Paz-Ares, Luis;
Filvaroff, Ellen H.;
Li, Shaoyi;
Hege, Kristen;
de Haan, Hans;
Mita, Monica

Publication type:

Article

Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients.

Published in:

2017

By:

Mahadevan, D.;
Mita, Monica;
Richards, Donald;
McClay, Edward;
Heist, Rebecca;
Kumar, A.;
Sundararajan, S.;
Naing, Aung;
Heist, Rebecca Suk

Publication type:

journal article

Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic disease.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 4, p. 701, doi. 10.1007/s00280-015-2682-2

By:

Chan, Emily;
Kwak, Eunice;
Hwang, Jimmy;
Heiskala, Marja;
Bourdonnaye, Guillaume;
Mita, Monica

Publication type:

Article

Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1113, doi. 10.1007/s00280-014-2572-z

By:

Sarantopoulos, John;
Mita, Alain;
Wade, James;
Morris, John;
Rixe, Olivier;
Mita, Monica;
Dedieu, Jean-François;
Wack, Claudine;
Kassalow, Laurent;
Craig Lockhart, A.

Publication type:

Article

Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors.

Published in:

2014

By:

Mita, Monica;
Gordon, Michael;
Rosen, Lee;
Kapoor, Nirmal;
Choy, Gavin;
Redkar, Sanjeev;
Taverna, Pietro;
Oganesian, Aram;
Sahai, Amarpal;
Azab, Mohammad;
Bristow, Robert;
Tolcher, Anthony

Publication type:

Report

Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 193, doi. 10.1007/s00280-012-1996-6

By:

LoRusso, Patricia;
Piha-Paul, Sarina;
Mita, Monica;
Colevas, A.;
Malhi, Vikram;
Colburn, Dawn;
Yin, Ming;
Low, Jennifer;
Graham, Richard

Publication type:

Article

Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 35, doi. 10.1007/s00280-012-1963-2

By:

Nemunaitis, John;
Mita, Alain;
Stephenson, Joe;
Mita, Monica;
Sarantopoulos, John;
Padmanabhan-Iyer, Swami;
Nanda, Nisha;
Gleich, Lyon;
Benichou, Annie-Claude;
Craig, Adam

Publication type:

Article

Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies.

Published in:

2012

By:

Zhang, Da;
Mita, Monica;
Shapiro, Geoffrey;
Poon, Jennifer;
Small, Karen;
Tzontcheva, Anjela;
Kantesaria, Bhavna;
Zhu, Yali;
Bannerji, Rajat;
Statkevich, Paul

Publication type:

Report

Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trial.

Published in:

2012

By:

Berk, Lori;
Mita, Monica;
Kreisberg, Jeff;
Bedrosian, Camille;
Tolcher, Anthony;
Clackson, Tim;
Rivera, Victor

Publication type:

Report

Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 287, doi. 10.1007/s00280-008-0869-5

By:

Mita, Monica;
Mita, Alain;
Sarantopoulos, John;
Takimoto, Chris H.;
Rowinsky, Eric K.;
Romero, Ofelia;
Angiuli, Patrizia;
Allievi, Cecilia;
Eisenfeld, Amy;
Verschraegen, Claire F.

Publication type:

Article

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x

By:

Chia-Chi Lin;
Calvo, Emiliano;
Papadopoulos, Kyriakos P.;
Patnaik, Amita;
Sarantopoulos, John;
Mita, Alain C.;
Preston, Glenn G.;
Mita, Monica M.;
Rodon, Jordi;
Mays, Theresa;
I.-Tien Yeh;
O'Rourke, Pat;
Takimoto, Chris H.;
Dancey, Janet E.;
Chen, Helen;
Tolcher, Anthony W.

Publication type:

Article

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 165, doi. 10.1007/s00280-006-0255-0

By:

Mita, Monica M.;
Rowinsky, Eric K.;
Forero, Leonardo;
Eckhart, S. Gail;
Izbicka, Elzbieta;
Weiss, Geoffrey R.;
Beeram, Muralidhar;
Mita, Alain C.;
de Bono, Johann S.;
Tolcher, Anthony W.;
Hammond, Lisa A.;
Simmons, Paul;
Berg, Kristin;
Takimoto, Chris;
Patnaik, Amita

Publication type:

Article

Aldoxorubicin for the treatment of soft tissue sarcoma.

Published in:

Expert Opinion on Investigational Drugs, 2017, v. 26, n. 10, p. 1175, doi. 10.1080/13543784.2017.1371134

By:

Sachdev, Esha;
Sachdev, Divesh;
Mita, Monica

Publication type:

Article

Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer.

Published in:

2020

By:

Vail, Eric;
Song, Jianbo;
Xu, Jing;
Frye, Joseph S.;
Kim, Jong Taek;
Pao, Andy;
Schreck, Rhona;
Aguiluz, Angela S.;
Zhang, Wenjuan;
Alkan, Serhan;
Mita, Alain;
Mita, Monica;
Figlin, Robert A.;
Engman, David M.;
Lopategui, Jean R.

Publication type:

journal article

PARP Inhibition in Cancer: An Update on Clinical Development.

Published in:

2019

By:

Sachdev, Esha;
Tabatabai, Roya;
Roy, Varun;
Rimel, B. J.;
Mita, Monica M.

Publication type:

journal article

Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.

Published in:

2017

By:

Tabatabai, Roya;
Linhares, Yuliya;
Bolos, David;
Mita, Monica;
Mita, Alain

Publication type:

journal article

The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.

Published in:

2016

By:

Gong, Jun;
Kelekar, Gauri;
Shen, James;
Shen, John;
Kaur, Sukhpreet;
Mita, Monica

Publication type:

journal article

Partial response of a rare malignant metastatic diffuse tenosynovial giant cell tumor with benign histologic features, treated with SCH 717-454, an insulin growth factor receptor inhibitor, in combination with everolimus, an MTOR inhibitor.

Published in:

Targeted Oncology, 2014, v. 9, n. 1, p. 73, doi. 10.1007/s11523-013-0267-8

By:

Sikaria, Swati;
Heim-Hall, Josefine;
Diaz, Elizabeth;
Williams, Ronald;
Sankhala, Kamelesh;
Laabs, Brenda;
Mita, Monica

Publication type:

Article

Are we ready to move away from nature?: the rapamycin story.

Published in:

2011

By:

Mita, Monica;
Mita, Alain

Publication type:

journal article

The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas.

Published in:

2011

By:

Vemulapalli, Sushma;
Mita, Alain;
Alvarado, Yesid;
Sankhala, Kamalesh;
Mita, Monica

Publication type:

journal article

The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents.

Published in:

2009

By:

Sankhala, Kamalesh;
Mita, Alain;
Kelly, Kevin;
Mahalingam, Devalingam;
Giles, Francis;
Mita, Monica

Publication type:

journal article

Apoptosis: mechanisms and implications for cancer therapeutics.

Published in:

Targeted Oncology, 2006, v. 1, n. 4, p. 197, doi. 10.1007/s11523-006-0034-1

By:

Mita, Monica;
Mita, Alain;
Tolcher, Anthony

Publication type:

Article

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.

Published in:

Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 10, p. 2448, doi. 10.1111/j.1582-4934.2009.00832.x

By:

Carew, Jennifer S.;
Medina, Ernest C.;
Esquivel II, Juan A.;
Mahalingam, Devalingam;
Swords, Ronan;
Kelly, Kevin;
Zhang, Hui;
Huang, Peng;
Mita, Alain C.;
Mita, Monica M.;
Giles, Francis J.;
Nawrocki, Steffan T.

Publication type:

Article

Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer.

Published in:

Clinical Breast Cancer, 2014, v. 14, n. 3, p. 169, doi. 10.1016/j.clbc.2013.10.016

By:

Mita, Monica M.;
Joy, Anil A.;
Mita, Alain;
Sankha, Kamalesh;
Ying-Ming Jou;
Da Zhang;
Statkevich, Paul;
Yali Zhu;
Siu-Long Yao;
Small, Karen;
Bannerji, Rajat;
Shapiro, Charles L.

Publication type:

Article

A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.

Published in:

Cancers, 2018, v. 10, n. 6, p. 160, doi. 10.3390/cancers10060160

By:

Mahalingam, Devalingam;
Goel, Sanjay;
Aparo, Santiago;
Patel Arora, Sukeshi;
Noronha, Nicole;
Tran, Hue;
Chakrabarty, Romit;
Selvaggi, Giovanni;
Gutierrez, Andres;
Coffey, Matthew;
Nawrocki, Steffan T.;
Nuovo, Gerard;
Mita, Monica M.

Publication type:

Article

Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.

Published in:

Investigational New Drugs, 2023, v. 41, n. 2, p. 284, doi. 10.1007/s10637-023-01342-x

By:

Jimeno, Antonio;
Baranda, Joaquina;
Iams, Wade T.;
Park, Jong Chul;
Mita, Monica;
Gordon, Michael S.;
Taylor, Matthew;
Dhani, Neesha;
Leal, Alexis D.;
Neupane, Prakash;
Eng, Cathy;
Yeku, Oladapo;
Mita, Alain;
Moser, Justin C.;
Butler, Marcus;
Loughhead, Scott M.;
Jennings, Julia;
Miselis, Nathan R.;
Ji, Rui-Ru;
Nair, Nitya

Publication type:

Article

Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2017, v. 35, n. 5, p. 616, doi. 10.1007/s10637-017-0442-3

By:

Mita, Monica;
Fu, Siqing;
Piha-Paul, Sarina;
Janku, Filip;
Mita, Alain;
Natale, Ronald;
Guo, Wei;
Zhao, Charles;
Kurzrock, Razelle;
Naing, Aung

Publication type:

Article

Pharmacokinetic study of aldoxorubicin in patients with solid tumors.

Published in:

Investigational New Drugs, 2015, v. 33, n. 2, p. 341, doi. 10.1007/s10637-014-0183-5

By:

Mita, Monica;
Natale, Ronald;
Wolin, Edward;
Laabs, Brenda;
Dinh, Hillary;
Wieland, Scott;
Levitt, Daniel;
Mita, Alain

Publication type:

Article

Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2014, v. 32, n. 6, p. 1236, doi. 10.1007/s10637-014-0145-y

By:

Lockhart, A.;
Sundaram, Shankar;
Sarantopoulos, John;
Mita, Monica;
Wang-Gillam, Andrea;
Moseley, Jennifer;
Barber, Stephanie;
Lane, Alex;
Wack, Claudine;
Kassalow, Laurent;
Dedieu, Jean-François;
Mita, Alain

Publication type:

Article

A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors.

Published in:

Investigational New Drugs, 2013, v. 31, n. 4, p. 974, doi. 10.1007/s10637-013-9930-2

By:

Sharma, Sunil;
Beck, Joachim;
Mita, Monica;
Paul, Sofia;
Woo, Margaret;
Squier, Margaret;
Gadbaw, Brian;
Prince, H.

Publication type:

Article

Metabolism of patupilone in patients with advanced solid tumor malignancies.

Published in:

Investigational New Drugs, 2013, v. 31, n. 3, p. 605, doi. 10.1007/s10637-012-9838-2

By:

Kelly, Kevin;
Zollinger, Markus;
Lozac'h, Frédéric;
Tan, Eugene;
Mita, Alain;
Waldmeier, Felix;
Urban, Patrick;
Anand, Suraj;
Wang, Yanfeng;
Swart, Piet;
Takimoto, Chris;
Mita, Monica

Publication type:

Article

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel.

Published in:

Investigational New Drugs, 2012, v. 30, n. 3, p. 1065, doi. 10.1007/s10637-011-9642-4

By:

Millward, Michael;
Mainwaring, Paul;
Mita, Alain;
Federico, Kristine;
Lloyd, G.;
Reddinger, Natasha;
Nawrocki, Steffan;
Mita, Monica;
Spear, Matthew

Publication type:

Article

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 359, doi. 10.1007/s10637-006-9031-6

By:

Quincy Chu;
Bahram Forouzesh;
Samira Syed;
Monica Mita;
Garry Schwartz;
Joshua Copper;
Janet Curtright;
Eric Rowinsky

Publication type:

Article

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes.

Published in:

Investigational New Drugs, 2007, v. 25, n. 4, p. 357, doi. 10.1007/s10637-007-9047-6

By:

Quincy Chu;
Bahram Forouzesh;
Samira Syed;
Monica Mita;
Garry Schwartz;
Joshua Cooper;
Janet Curtright;
Eric Rowinsky

Publication type:

Article

First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.

Published in:

Cancer Management & Research, 2019, v. 11, p. 10463, doi. 10.2147/CMAR.S208720

By:

Munster, Pamela;
Mita, Monica;
Mahipal, Amit;
Nemunaitis, John;
Massard, Christophe;
Mikkelsen, Tom;
Cruz, Cristina;
Paz-Ares, Luis;
Hidalgo, Manuel;
Rathkopf, Dana;
Jr, George Blumenschein;
Smith, David C;
Eichhorst, Barbara;
Cloughesy, Tim;
Filvaroff, Ellen H;
Li, Shaoyi;
Raymon, Heather;
Haan, Hans de;
Hege, Kristen;
Bendell, Johanna C

Publication type:

Article

Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.

Published in:

Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01132-z

By:

Tsimberidou, Apostolia-Maria;
Shaw, Jamie V.;
Juric, Dejan;
Verschraegen, Claire;
Weise, Amy M.;
Sarantopoulos, John;
Lopes, Gilberto;
Nemunaitis, John;
Mita, Monica;
Park, Haeseong;
Ellers-Lenz, Barbara;
Tian, Hui;
Xiong, Wenyuan;
Kaleta, Remigiusz;
Kurzrock, Razelle

Publication type:

Article

Combined autophagy and HDAC inhibition.

Published in:

Autophagy, 2014, v. 10, n. 8, p. 1403, doi. 10.4161/auto.29231

By:

Mahalingam, Devalingam;
Mita, Monica;
Sarantopoulos, John;
Wood, Leslie;
Amaravadi, Ravi K.;
Davis, Lisa E.;
Mita, Alain C.;
Curiel, Tyler J.;
Espitia, Claudia M.;
Nawrocki, Steffan T.;
Giles, Francis J.;
Carew, Jennifer S.

Publication type:

Article

Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 8, p. 1421, doi. 10.1002/mc.23738

By:

Weaver, Alice N.;
Iams, Wade T.;
Park, Jong Chul;
Mita, Monica;
Holtick, Udo;
Gordon, Michael S.;
Rodabaugh, Kerry J.;
Dhani, Neesha;
Neupane, Prakash;
Taylor, Matthew;
Amanda Duvall, E.;
Jennings, Julia;
Miselis, Nathan R.;
Loughhead, Scott;
Warren, Marshelle S.;
Bernstein, Howard;
Klussmann, Jens P.;
Baranda, Joaquina;
Jimeno, Antonio

Publication type:

Article

Statins and pancreatic cancer (Review).

Published in:

Oncology Letters, 2017, v. 13, n. 3, p. 1035, doi. 10.3892/ol.2017.5572

By:

JUN GONG;
SACHDEV, ESHA;
ROBBINS, LORI A.;
LIN, EMILY;
HENDIFAR, ANDREW E.;
MITA, MONICA M.

Publication type:

Article

Activated Ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells.

Published in:

Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00167

By:

Jun Gong;
Mita, Monica M.

Publication type:

Article